CY1123083T1 - Παραγωγα βενζιμιδαζολιου ως διπλοι προσδετες υποδοχεων η1 ισταμινης και η4 ισταμινης - Google Patents

Παραγωγα βενζιμιδαζολιου ως διπλοι προσδετες υποδοχεων η1 ισταμινης και η4 ισταμινης

Info

Publication number
CY1123083T1
CY1123083T1 CY20201100593T CY201100593T CY1123083T1 CY 1123083 T1 CY1123083 T1 CY 1123083T1 CY 20201100593 T CY20201100593 T CY 20201100593T CY 201100593 T CY201100593 T CY 201100593T CY 1123083 T1 CY1123083 T1 CY 1123083T1
Authority
CY
Cyprus
Prior art keywords
histamine
dual
receptor
addendors
benzimidazole derivatives
Prior art date
Application number
CY20201100593T
Other languages
English (en)
Inventor
Isabelle Berrebi-Bertrand
Xavier Billot
Thierry Calmels
Marc Capet
Stéphane Krief
Olivier Labeeuw
Jeanne-Marie Lecomte
Nicolas Levoin
Xavier Ligneau
Philippe Robert
Jean-Charles Schwartz
Original Assignee
Bioprojet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet filed Critical Bioprojet
Publication of CY1123083T1 publication Critical patent/CY1123083T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα αίτηση αφορά νέα εναντιομερικά παράγωγα βενζιμιδαζολίου, τη διαδικασία παρασκευής τους και τις θεραπευτικές χρήσεις τους ως διπλοί προσδέτες Η1 και Η4 υποδοχέα.
CY20201100593T 2017-11-15 2020-06-26 Παραγωγα βενζιμιδαζολιου ως διπλοι προσδετες υποδοχεων η1 ισταμινης και η4 ισταμινης CY1123083T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17306587 2017-11-15

Publications (1)

Publication Number Publication Date
CY1123083T1 true CY1123083T1 (el) 2021-10-29

Family

ID=60473453

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100593T CY1123083T1 (el) 2017-11-15 2020-06-26 Παραγωγα βενζιμιδαζολιου ως διπλοι προσδετες υποδοχεων η1 ισταμινης και η4 ισταμινης

Country Status (22)

Country Link
US (2) US11306069B2 (el)
EP (1) EP3486243B1 (el)
JP (2) JP2019089761A (el)
KR (1) KR20190055775A (el)
CN (1) CN109824651A (el)
AU (1) AU2018264079B2 (el)
BR (1) BR102018073582A2 (el)
CA (1) CA3024429A1 (el)
CY (1) CY1123083T1 (el)
DK (1) DK3486243T3 (el)
ES (1) ES2807191T3 (el)
HR (1) HRP20200791T1 (el)
HU (1) HUE050735T2 (el)
IL (1) IL263063B (el)
LT (1) LT3486243T (el)
MX (1) MX2018014033A (el)
PL (1) PL3486243T3 (el)
PT (1) PT3486243T (el)
RS (1) RS60320B1 (el)
SI (1) SI3486243T1 (el)
TW (1) TWI787392B (el)
ZA (1) ZA201807674B (el)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683191B2 (en) * 2000-06-05 2004-01-27 Ortho-Mcneil Pharmaceuticals, Inc. Method for synthesis of substituted azole libraries
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
EP2447263A1 (en) * 2010-09-27 2012-05-02 Bioprojet Benzazole derivatives as histamine H4 receptor ligands

Also Published As

Publication number Publication date
IL263063B (en) 2021-09-30
AU2018264079A1 (en) 2019-05-30
MX2018014033A (es) 2019-06-10
TWI787392B (zh) 2022-12-21
US20220281839A1 (en) 2022-09-08
BR102018073582A2 (pt) 2020-07-07
EP3486243B1 (en) 2020-04-15
TW201922727A (zh) 2019-06-16
AU2018264079B2 (en) 2022-06-30
US20190144421A1 (en) 2019-05-16
JP2023112012A (ja) 2023-08-10
ZA201807674B (en) 2019-09-25
PT3486243T (pt) 2020-06-22
RS60320B1 (sr) 2020-07-31
US11306069B2 (en) 2022-04-19
SI3486243T1 (sl) 2020-07-31
CA3024429A1 (en) 2019-05-15
LT3486243T (lt) 2020-07-27
JP2019089761A (ja) 2019-06-13
CN109824651A (zh) 2019-05-31
HRP20200791T1 (hr) 2020-07-24
HUE050735T2 (hu) 2021-01-28
DK3486243T3 (da) 2020-06-08
KR20190055775A (ko) 2019-05-23
ES2807191T3 (es) 2021-02-22
PL3486243T3 (pl) 2020-10-19
EP3486243A1 (en) 2019-05-22
IL263063A (en) 2019-03-31

Similar Documents

Publication Publication Date Title
CY1123845T1 (el) Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων
DK3283521T3 (da) Lægemiddelkonjugater, der omfatter antistoffer mod claudin 18.2
EA201990293A1 (ru) Мультиспецифичные антитела против cd40 и cd137
BR112018003269A2 (pt) conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização
EA201890126A1 (ru) Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их
CL2016001737A1 (es) Derivados heterocíclicos bicíclicos como inhibidores de bromodominio
CL2015003280A1 (es) Derivados de benzimidazol como inhibidores de bromodominio
BR112017007636A2 (pt) métodos para a preparação de ribosídeos
EA201600091A1 (ru) 4-членные кольцевые карбоксамиды, применяемые в качестве нематоцидов
EA201691194A1 (ru) Стимуляторы ргц
CY1121089T1 (el) Χρηση των παραγωγων της βενζιμιδαζολης-προλινης
DK3513809T3 (da) Medicinsk sammensætning, som omfatter tivozanib
CR20130547A (es) Composiciòn que comprende aflibercept, àcido folìnico, 5-fluorouracilo (5-fu) e irinocetan (folfiri)
CY1119619T1 (el) Παραγωγα πυριδιν-4-υλιου
CY1120697T1 (el) Τροποποιημενη σουλφαμιδαση και παραγωγη αυτης
CY1122822T1 (el) Σακχαριτες παραγωγοποιημενοι με κυκλοαλκινιο
BR112018068412A2 (pt) composto, composição farmacêutica, método de tratamento de síndrome mielodisplásica e método para matar uma célula tumoral
BR112017000730B8 (pt) Derivados de pirrolidinona como inibidores de metap-2, e medicamentos
BR112018010279A2 (pt) novos anticorpos anti-emr2 e métodos de uso
EA202090620A1 (ru) Энантиомеры замещенных тиазолов в качестве противовирусных соединений
EA201691982A1 (ru) 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
PH12017501820A1 (en) Ribociclib tablet
CY1121156T1 (el) Μεθοδοι αντιμετωπισης ινωσης και καρκινων
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта